Taurochenodeoxycholic acid
-
Taurochenodeoxycholic acid
structure -
-
CAS No:
516-35-8
-
Formula:
C26H45NO6S
-
Chemical Name:
Taurochenodeoxycholic acid
-
Synonyms:
Ethanesulfonic acid,2-[[(3α,5β,7α)-3,7-dihydroxy-24-oxocholan-24-yl]amino]-;Taurochenodeoxycholic acid;Taurine,N-(3α,7α-dihydroxy-5β-cholan-24-oyl)-;Cholane,ethanesulfonic acid deriv.;2-[[(3α,5β,7α)-3,7-Dihydroxy-24-oxocholan-24-yl]amino]ethanesulfonic acid;12-Deoxycholyltaurine;12-Desoxycholyltaurine;Chenodeoxycholyltaurine;Taurochenodesoxycholic acid;3α,7α-Dihydroxy-N-(2-sulfoethyl)-5β-cholan-24-amide;Chenyltaurine
- Categories:
-
CAS No:
Description
Taurochenodeoxycholic acid is one of the main bioactive substances of animals' bile acid.
Solid
Taurochenodeoxycholic acid is a bile acid taurine conjugate of chenodeoxycholic acid. It has a role as a mouse metabolite and a human metabolite. It derives from a chenodeoxycholic acid. It is a conjugate acid of a taurochenodeoxycholate.|Taurochenodeoxycholic acid is an experimental drug that is normally produced in the liver. Its physiologic function is to emulsify lipids such as cholesterol in the bile. As a medication, taurochenodeoxycholic acid reduces cholesterol formation in the liver, and is likely used as a choleretic to increase the volume of bile secretion from the liver and as a cholagogue to increase bile discharge into the duodenum. It is also being investigated for its role in inflammation and cancer therapy.|A bile salt formed in the liver by conjugation of chenodeoxycholate with taurine, usually as the sodium salt. It acts as detergent to solubilize fats in the small intestine and is itself absorbed. It is used as a cholagogue and choleretic.
Characteristics
132
4.86900
Solid
1.2±0.1 g/cm3
1.552
207.4 Ų [M+Na]+ [CCS Type: DT, Method: single field calibrated with Agilent tune mix (Agilent)]|205.39 Ų [M-H]- [CCS Type: DT, Method: single field calibrated with Agilent tune mix (Agilent)]|221.75 Ų [M-H]- [CCS Type: DT, Method: stepped-field]|207.2 Ų [M-H]- [CCS Type: DT, Method: single field calibrated]|218.7 Ų [M+H-2H2O]+ [CCS Type: DT, Method: single field calibrated]
Drug Information
Taurochenodeoxycholic acid is likely indicated as a choleretic and cholagogue. It is also being investigated for its role in inflammation and cancer therapy.
Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). (See all compounds classified as Cholagogues and Choleretics.)|Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties. (See all compounds classified as Detergents.)
Chenodeoxycholic acid is a primary bile acid in the liver that combines with taurine to form the bile acid taurochenodeoxycholic acid. In the bile, taurochenodeoxycholic acid is either a sodium (most) or potassium salt. Taurochenodeoxycholic acid is normally produced in the liver, and its physiologic function as a bile salt is to emulsify lipids such as cholesterol in the bile. As a medication, taurochenodeoxycholic acid reduces cholesterol formation in the liver, and is likely used as a choleretic to increase the volume of bile secretion from the liver and as a cholagogue to increase bile discharge into the duodenum. The mechanism of action of taurochenodeoxycholic acid in inflammation and cancer has yet to be determined.
Acid, Taurochenodeoxycholic
Taurochenodeoxycholic acid Use and Manufacturing
Under room temperature, will be of ursodesoxycholic acid 10.0g (25.4mmol) and P-nitro phenol 3.54g (25.4mmol) by adding 100 ml methylene chloride, stirring cooling to 10-20°C. Dropwise N, N '-dicyclohexyl carbodiimide 5.25g (25.4mmol) dichloromethane solution, completion of the dropping, 20-45 °C reaction 2 hours, filtering, for removing insoluble matter, the filtrate concentrated to obtain yellowish oily 12.59g, yield 96.3percent.The above-mentioned oil to b the nitrile is heavy crystallization, to obtain white adhesive material, directly used for the next step reaction.Under room temperature, the taurine potassium 18-crown -6 complexes 15.73g (36.8mmol) and such oils by adding dichloromethane in sheet, stirring. Reaction at room temperature 5 hours later, TLC (ethyl acetate: petroleum ether = 1:1) monitoring, the reaction is complete. Adding 0.21g glacial acetic acid, stirring a large amount of solid precipitated, filtering to obtain the white solid, the above-mentioned white solid by adding 20 ml in water, stirring crystallization. Filtering and drying to obtain solid 11.56g, total yield 84.7percent (purity 99.8percent, HPLC), deoxycholic acid niu Huange not be detected, the largest unknown shan Za 0.04percent.Under room temperature, will be of ursodesoxycholic acid 10.0g (25.4mmol) and phenol 2.39g (25.4mmol) by adding 100 ml methylene chloride, stirring cooling to 10-20°C. Dropwise N, N '-dicyclohexyl carbodiimide 5.25g (25.4mmol) dichloromethane solution, completion of the dropping, 5-20 °C reaction 2 hours, filtering, for removing insoluble matter, the filtrate concentrated to obtain yellowish oily 11.45g, yield 96.0percent.The above-mentioned oil to b the nitrile is heavy crystallization, to obtain white adhesive material, directly used for the next step reaction.Under room temperature, the taurine potassium 18-crown -6 complexes 15.68g (36.7mmol) and such oils by adding dichloromethane in sheet, stirring. Reaction at room temperature 5 hours later, TLC (ethyl acetate: petroleum ether = 1:1) monitoring, the reaction is complete. Adding 0.19g glacial acetic acid, stirring a large amount of solid precipitated, filtering to obtain the white solid, the above-mentioned white solid by adding 20 ml in water, stirring crystallization. Filtering and drying to obtain solid 11.63g, the overall yield is 85.2percent (purity 99.7percent, HPLC), deoxycholic acid niu Huange not be detected, the largest unknown shan Za 0.04percent.
Taurochenodeoxycholic Acid is a bile acid conjugate and metabolite Taurolithocholic Acid (T009100) with antiinflammatory activity. Taurochenodeoxycholic Acid has been shown to inhibit hepatocyte apoptosis through suppression of Bid translocation to mitochondria.
Lipids -> Sterol Lipids [ST] -> Steroid conjugates [ST05] -> Taurine conjugates [ST0504]
Computed Properties
Molecular Weight:499.7
XLogP3:3.6
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:7
Exact Mass:499.29675933
Monoisotopic Mass:499.29675933
Topological Polar Surface Area:132
Heavy Atom Count:34
Complexity:858
Defined Atom Stereocenter Count:10
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of Taurochenodeoxycholic acid
-
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of Chemical Pesticides,Food Additives,Agrochemicals,Active Pharm Ingredients,Flavors and Fragrances,Chemical Catalyst,Chemical Materials,Chem&Pharm Intermediates,Organic Intermediates,Feed AdditiveInquiryCAS No.: 516-35-8Grade: Pharmaceutical GradeContent: 99% -
CN
8 YRS
Business licensed Certified factoryManufactory Supplier of Biochemicals Ingredients,Vitamin Amino Acid Ingredients,Cosmestic Ingredients,Pharma Chemicals,Organic Fine Chemicals,Food Nutrient Ingredients,Natural Plant Ingredients,APIS Intermidiates,Daily Chemicals,Agricultural Chemicals,Surfactant Chemicals,Ultraviolet Absorbents,Antioxidant Ingredients,Scientific Research Chemical,Flavors and Fragrances ChemicalsInquiryCAS No.: 516-35-8Grade: Pharmaceutical GradeContent: 99% -
CN
3 YRS
Business licensedTrader Supplier of semaglutide,tirzepatide,Liraglutide,Retatrutide,5-amino-1MQ,SLU-PP-332,Bam-15,Spermidine HCL,ghk-cu,ss31,FOXO-4 DRIInquiryCAS No.: 516-35-8Grade: Pharmaceutical GradeContent: 99%
Learn More Other Chemicals
-
3,5-DIBROMO-2-[[[(3,5-DINITROBENZOYL)AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID
535965-38-9
-
3,5-DIBROMO-2-[[[[(2-CHLOROPHENOXY)ACETYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID
532386-89-3
-
3,5-DIBROMO-2-[[[(4-METHYL-3-NITROBENZOYL)AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID
532943-48-9
-
3,5-DIBROMO-2-[[[[3-(2-FURANYL)-1-OXO-2-PROPENYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID Formula
586392-09-8
-
3,5-DIBROMO-2-[[[[(2-METHYLPHENOXY)ACETYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID Formula
531548-30-8
-
2-(1,8-dibromo-16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)benzoic acid Formula
333340-54-8
-
3,5-DIBROMO-2-[[[[3-(PHENOXYMETHYL)BENZOYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID Structure
586393-79-5
-
3,5-DIBROMO-2-[[[(4-CHLOROBENZOYL)AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID Structure
531530-32-2
-
What is 2-Cyclopentyl-3-(2,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-oxo-4-isoquinolinecarboxylic acid
400073-92-9
-
What is 9-Octadecenoic acid (9Z)-, compd. with N,N-dimethylcyclohexanamine (1:1)
65122-23-8
- Hot Searches
- fluorene
- sodium amytal
- cefepime drug
- amytal sodium
- ethyl sulfate
- triacetin